EDP‐297: A novel, farnesoid X receptor agonist-Results of a phase I study in healthy subjects

Abstract EDP‐297 is a farnesoid X receptor agonist under development for treating nonalcoholic steatohepatitis. The pharmacokinetic (PK), pharmacodynamic (PD), food effect, and safety were evaluated in a single ascending dose (SAD) and multiple ascending dose (MAD) phase I study. Healthy subjects re...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Christine Marotta (Egilea), Alaa Ahmad (Egilea), Ed Luo (Egilea), Jart Oosterhaven (Egilea), Sjoerd vanMarle (Egilea), Nathalie Adda (Egilea)
Formatua: Liburua
Argitaratua: Wiley, 2023-02-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Internet

Connect to this object online.

3rd Floor Main Library

Aleari buruzko argibideak 3rd Floor Main Library
Sailkapena: A1234.567
Alea 1 Eskuragarri